Menu
GeneBe

1-70415987-C-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP3BP4_StrongBS2

The NM_001902.6(CTH):c.200C>T(p.Thr67Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00803 in 1,610,620 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0067 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0082 ( 71 hom. )

Consequence

CTH
NM_001902.6 missense

Scores

11
4
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:4

Conservation

PhyloP100: 6.10
Variant links:
Genes affected
CTH (HGNC:2501): (cystathionine gamma-lyase) This gene encodes a cytoplasmic enzyme in the trans-sulfuration pathway that converts cystathione derived from methionine into cysteine. Glutathione synthesis in the liver is dependent upon the availability of cysteine. Mutations in this gene cause cystathioninuria. Alternative splicing of this gene results in three transcript variants encoding different isoforms. [provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Dann, Eigen, MutationAssessor, PROVEAN, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.023492247).
BS2
High Homozygotes in GnomAd at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CTHNM_001902.6 linkuse as main transcriptc.200C>T p.Thr67Ile missense_variant 2/12 ENST00000370938.8
CTHNM_001190463.2 linkuse as main transcriptc.200C>T p.Thr67Ile missense_variant 2/11
CTHNM_153742.5 linkuse as main transcriptc.200C>T p.Thr67Ile missense_variant 2/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CTHENST00000370938.8 linkuse as main transcriptc.200C>T p.Thr67Ile missense_variant 2/121 NM_001902.6 P1P32929-1
CTHENST00000346806.2 linkuse as main transcriptc.200C>T p.Thr67Ile missense_variant 2/111 P32929-2
CTHENST00000411986.6 linkuse as main transcriptc.200C>T p.Thr67Ile missense_variant 2/112 P32929-3
CTHENST00000464926.1 linkuse as main transcriptn.344C>T non_coding_transcript_exon_variant 2/65

Frequencies

GnomAD3 genomes
AF:
0.00675
AC:
1027
AN:
152158
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00174
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00274
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00939
Gnomad OTH
AF:
0.00621
GnomAD3 exomes
AF:
0.00648
AC:
1628
AN:
251408
Hom.:
8
AF XY:
0.00629
AC XY:
855
AN XY:
135892
show subpopulations
Gnomad AFR exome
AF:
0.00142
Gnomad AMR exome
AF:
0.00766
Gnomad ASJ exome
AF:
0.0102
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00163
Gnomad FIN exome
AF:
0.00319
Gnomad NFE exome
AF:
0.00936
Gnomad OTH exome
AF:
0.00865
GnomAD4 exome
AF:
0.00816
AC:
11900
AN:
1458344
Hom.:
71
Cov.:
28
AF XY:
0.00794
AC XY:
5760
AN XY:
725702
show subpopulations
Gnomad4 AFR exome
AF:
0.00174
Gnomad4 AMR exome
AF:
0.00796
Gnomad4 ASJ exome
AF:
0.00843
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00166
Gnomad4 FIN exome
AF:
0.00391
Gnomad4 NFE exome
AF:
0.00943
Gnomad4 OTH exome
AF:
0.00720
GnomAD4 genome
AF:
0.00674
AC:
1027
AN:
152276
Hom.:
2
Cov.:
33
AF XY:
0.00666
AC XY:
496
AN XY:
74458
show subpopulations
Gnomad4 AFR
AF:
0.00171
Gnomad4 AMR
AF:
0.0149
Gnomad4 ASJ
AF:
0.0104
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00166
Gnomad4 FIN
AF:
0.00274
Gnomad4 NFE
AF:
0.00940
Gnomad4 OTH
AF:
0.00615
Alfa
AF:
0.00844
Hom.:
13
Bravo
AF:
0.00708
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.00804
AC:
31
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.0108
AC:
93
ExAC
AF:
0.00647
AC:
786
Asia WGS
AF:
0.00115
AC:
4
AN:
3476
EpiCase
AF:
0.00921
EpiControl
AF:
0.00996

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cystathioninuria Pathogenic:2Uncertain:2
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016The c.200C>T (p.Thr67Ile) variant has been reported in three studies in which it is found in a total of 13 cystathioninuria patients including five in a homozygous state, three in a compound heterozygous state, and a five in a heterozygous state (Wang et al. 2003; Kraus et al. 2009; Espinós et al. 2010). All individuals homozygous for the p.Thr67Ile variant showed a marked elevation of plasma cystathionine. The p.Thr67Ile variant was reported in a heterozygous state in a total of six out of 822 control alleles and is reported at a frequency of 0.01869 in the Iberian population in Spain cohort of the 1000 Genomes Project. This allele frequency is high but is consistent with the disease prevalence. Functional studies by Kraus et al. (2009) and Zhu et al. (2008) demonstrated that the p.Thr67Ile variant protein has decreased catalytic activity of 13 - 29% compared to wild type. Based on the collective evidence, the p.Thr67Ile variant is classified as a pathogenic variant for cystathioninuria. -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterApr 04, 2024- -
Pathogenic, no assertion criteria providedliterature onlyOMIMDec 01, 2010- -
Uncertain significance, criteria provided, single submitterclinical testingGenomic Research Center, Shahid Beheshti University of Medical SciencesApr 27, 2019- -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2024CTH: PP4:Moderate, PS3:Supporting -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 05, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Pathogenic
0.41
Cadd
Uncertain
26
Dann
Pathogenic
1.0
Eigen
Pathogenic
0.98
Eigen_PC
Pathogenic
0.92
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Pathogenic
0.98
D;D;D
MetaRNN
Benign
0.023
T;T;T
MetaSVM
Pathogenic
0.89
D
MutationAssessor
Pathogenic
3.5
M;M;M
MutationTaster
Benign
1.0
A;A;A
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-5.5
D;D;D
REVEL
Pathogenic
0.93
Sift
Pathogenic
0.0
D;D;D
Sift4G
Uncertain
0.027
D;D;D
Polyphen
1.0, 0.99
.;D;D
Vest4
0.87
MVP
0.99
MPC
0.66
ClinPred
0.063
T
GERP RS
5.5
Varity_R
0.94
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28941785; hg19: chr1-70881670; COSMIC: COSV61008730; API